SCHEMBL4026348

SCHEMBL4026348

Cc1cc2c(CCc3sc(-c4ccc(C(F)(F)F)cc4)nc3C(C)C)noc2cc1SCC(=O)O

nearest known ligand 0.71

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
PPARD Q03181 17/20 0.71
PPARA Q07869 15/20 0.71
PPARG P37231 10/20 0.71
FFAR1 O14842 4/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4803360 0.87 PPARD (0.68) PPARDPPARAPPARGFFAR1
SCHEMBL4026350 0.87 PPARD (0.54) PPARDPPARAPPARG
SCHEMBL4024973 0.85 PPARD (0.71) PPARDPPARAPPARGFFAR1
Fonadelpar SCHEMBL1765984 0.85 PPARD (0.81) PPARDPPARAPPARGFFAR1
SCHEMBL4033025 0.84 PPARD (0.73) PPARDPPARAPPARGFFAR1
SCHEMBL1765835 0.84 PPARD (0.70) PPARDPPARAPPARGFFAR1
SCHEMBL4025644 0.84 PPARD (0.71) PPARDPPARAPPARGFFAR1
SCHEMBL1765895 0.83 PPARA (1.00) PPARDPPARAPPARG
SCHEMBL4034566 0.83 PPARD (0.70) PPARDPPARAPPARGFFAR1
SCHEMBL4028013 0.83 PPARD (0.71) PPARDPPARAPPARGFFAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1445258-B1 ACTIVATOR FOR PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR DELTA NIPPON CHEMIPHAR CO (JP) 2009-06-24 EP disclosed
US-7119104-B2 Activator of peroxisome proliferator-activated receptor delta NIPPON CHEMIPHAR, CO., LTD. (JP) 2006-10-10 US disclosed
US-20050096363-A1 Activator of peroxisome proliferator-activated receptor delta NIPPON CHEMIPHAR CO., LTD. (JP) 2005-05-05 US disclosed
EP-1445258-A1 ACTIVATOR FOR PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR DELTA NIPPON CHEMIPHAR CO., LTD. (JP) 2004-08-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050096363-A1 Activator of peroxisome proliferator-activated receptor delta PPARA, PPARG, PPARD PPARD 3/4885PPARA 1/4885PPARG 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.